Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for METFORMIN HYDROCHLORIDE

Ingredient

METFORMIN HYDROCHLORIDE

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
APO-SITAGLIPTIN/METFORMIN XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-03-02	2024-02-02	185973
APO-SITAGLIPTIN/METFORMIN XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-12-16	2023-01-20	178775
APO-SITAGLIPTIN/METFORMIN XR	500MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-03-02	2024-02-02	185970
APO-SITAGLIPTIN/METFORMIN XR	50MG 1000MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-11-13	2026-01-30	271847
APO-SITAGLIPTIN/METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-03-02	2024-02-02	185967
APO-SITAGLIPTIN/METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-03-02	2024-02-02	185985
APO-SITAGLIPTIN/METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Resolved	2025-10-03	2025-10-16	268561
APO-SITAGLIPTIN/METFORMIN XR	1000MG 100MG	TABLET (EXTENDED-RELEASE)	Actual shortage	2026-01-23	2026-03-11	276559
APO-SITAGLIPTIN/METFORMIN XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2022-12-16	2023-01-09	178772
APO-SITAGLIPTIN/METFORMIN XR	1000MG 50MG	TABLET (EXTENDED-RELEASE)	Resolved	2023-03-02	2024-02-02	185982

Previous
1
…
4
5
6
7
8
…
19
Next

Showing 51 to 60 of 184

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-METFORMIN	500MG	TABLET	Reversed	2025-05-28	2025-06-04	258452

Previous
1
…
3
4
5

Showing 41 to 41 of 41